The global HIV diagnostics market is expected to grow at a CAGR of ~10% during the forecast period. Rising prevalence of HIV ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Federal departments and agencies have put out guidance about which programs will stay open and which ones won't during the ...

Pharmacogenomic testing can tell how a drug is likely to work in a certain person. But is it ready for rolling out to the ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke ...

Commercial chief Luke Miels will take the helm as the pharma company seeks to bring to replenish its product lineup to offset ...

Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...

Lupin's shares surged by 2.2% following tentative U.S. FDA approval for its generic HIV treatment, Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets. This positions Lupin to enter a ...

GSK CEO Emma Walmsley is stepping down next year after leading the company since 2017, aiming to pivot the U.K. firm into an innovative pharma company.

Two renewable energy projects are being developed: a 250 MW solar power project and a 370 MW hybrid project combining solar and wind power. Both have 25-year power purchase agreements with Gujarat ...